 Kimberly Simmons
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 27 | 2025 | 3628 | 3.380 |
Why?
| | Autoantibodies | 12 | 2025 | 1466 | 2.000 |
Why?
| | Insulin-Secreting Cells | 5 | 2023 | 367 | 1.590 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 36 | 0.710 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2021 | 32 | 0.710 |
Why?
| | Prediabetic State | 1 | 2023 | 246 | 0.690 |
Why?
| | HLA-DQ beta-Chains | 1 | 2020 | 61 | 0.670 |
Why?
| | Health Fairs | 1 | 2019 | 9 | 0.650 |
Why?
| | Insulin | 5 | 2023 | 2326 | 0.630 |
Why?
| | Autoimmunity | 3 | 2023 | 862 | 0.560 |
Why?
| | Celiac Disease | 2 | 2022 | 286 | 0.550 |
Why?
| | Insulin Antibodies | 1 | 2016 | 105 | 0.510 |
Why?
| | Dried Blood Spot Testing | 1 | 2016 | 94 | 0.510 |
Why?
| | HLA-D Antigens | 1 | 2014 | 34 | 0.460 |
Why?
| | Diet Therapy | 1 | 2014 | 34 | 0.450 |
Why?
| | Child | 19 | 2025 | 20883 | 0.430 |
Why?
| | Antibodies | 1 | 2015 | 398 | 0.430 |
Why?
| | Adolescent | 17 | 2025 | 20393 | 0.430 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2025 | 759 | 0.390 |
Why?
| | Islets of Langerhans | 5 | 2024 | 791 | 0.390 |
Why?
| | Mass Screening | 1 | 2019 | 1149 | 0.380 |
Why?
| | Bone Density | 1 | 2015 | 471 | 0.370 |
Why?
| | Blood Glucose | 1 | 2020 | 2097 | 0.350 |
Why?
| | Endocrinology | 2 | 2022 | 75 | 0.330 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 853 | 0.320 |
Why?
| | Child, Preschool | 9 | 2025 | 10517 | 0.320 |
Why?
| | Diabetes Complications | 2 | 2022 | 224 | 0.310 |
Why?
| | Humans | 31 | 2025 | 129650 | 0.310 |
Why?
| | Infant | 9 | 2025 | 9024 | 0.290 |
Why?
| | Diabetic Ketoacidosis | 3 | 2025 | 197 | 0.290 |
Why?
| | Hypoglycemic Agents | 2 | 2023 | 1220 | 0.280 |
Why?
| | Risk Assessment | 3 | 2023 | 3240 | 0.260 |
Why?
| | Disease Progression | 5 | 2024 | 2635 | 0.250 |
Why?
| | HLA Antigens | 2 | 2025 | 234 | 0.240 |
Why?
| | Age of Onset | 3 | 2025 | 496 | 0.230 |
Why?
| | Male | 12 | 2025 | 63681 | 0.190 |
Why?
| | Female | 12 | 2025 | 68776 | 0.180 |
Why?
| | Hyperglycemia | 1 | 2024 | 328 | 0.180 |
Why?
| | Obesity Management | 1 | 2020 | 8 | 0.180 |
Why?
| | Consensus | 4 | 2024 | 616 | 0.160 |
Why?
| | Quality of Life | 2 | 2023 | 2704 | 0.160 |
Why?
| | Diagnostic Techniques, Endocrine | 1 | 2019 | 14 | 0.160 |
Why?
| | Clinical Protocols | 1 | 2021 | 255 | 0.160 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 35 | 0.160 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 356 | 0.160 |
Why?
| | Young Adult | 5 | 2025 | 12426 | 0.160 |
Why?
| | Methylation | 1 | 2019 | 230 | 0.150 |
Why?
| | Haplotypes | 1 | 2020 | 475 | 0.150 |
Why?
| | Nutritional Status | 1 | 2021 | 328 | 0.150 |
Why?
| | Cell Death | 1 | 2019 | 354 | 0.140 |
Why?
| | Community Health Services | 1 | 2019 | 227 | 0.140 |
Why?
| | Caregivers | 1 | 2025 | 815 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2019 | 333 | 0.140 |
Why?
| | Alleles | 1 | 2020 | 845 | 0.140 |
Why?
| | Hypophosphatemia | 1 | 2017 | 17 | 0.140 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2016 | 27 | 0.130 |
Why?
| | Colorado | 3 | 2024 | 4421 | 0.130 |
Why?
| | Radioimmunoassay | 1 | 2016 | 175 | 0.130 |
Why?
| | Risk | 1 | 2019 | 854 | 0.130 |
Why?
| | Disease Management | 1 | 2020 | 589 | 0.130 |
Why?
| | Bone Diseases | 1 | 2017 | 57 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 601 | 0.130 |
Why?
| | Infant Formula | 1 | 2017 | 74 | 0.130 |
Why?
| | Patient Education as Topic | 1 | 2021 | 743 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2023 | 1501 | 0.120 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 373 | 0.120 |
Why?
| | Abatacept | 1 | 2014 | 46 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2014 | 41 | 0.110 |
Why?
| | Niacinamide | 1 | 2014 | 75 | 0.110 |
Why?
| | Diabetic Nephropathies | 1 | 2017 | 284 | 0.110 |
Why?
| | Early Medical Intervention | 1 | 2014 | 57 | 0.110 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2019 | 601 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 755 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2020 | 572 | 0.110 |
Why?
| | Secondary Prevention | 1 | 2014 | 218 | 0.100 |
Why?
| | Immunoconjugates | 1 | 2014 | 103 | 0.100 |
Why?
| | Autoantigens | 1 | 2015 | 417 | 0.100 |
Why?
| | Primary Prevention | 1 | 2014 | 188 | 0.100 |
Why?
| | Chronic Disease | 1 | 2019 | 1720 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2017 | 815 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2282 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 426 | 0.090 |
Why?
| | Pediatrics | 1 | 2018 | 1052 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5066 | 0.080 |
Why?
| | Adult | 4 | 2025 | 35576 | 0.080 |
Why?
| | Middle Aged | 3 | 2025 | 31154 | 0.080 |
Why?
| | Risk Factors | 1 | 2023 | 9765 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1368 | 0.080 |
Why?
| | Biomarkers | 1 | 2019 | 3973 | 0.070 |
Why?
| | Prevalence | 2 | 2024 | 2564 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1838 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2022 | 704 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2015 | 5762 | 0.060 |
Why?
| | CD3 Complex | 1 | 2023 | 103 | 0.050 |
Why?
| | C-Peptide | 1 | 2023 | 163 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2023 | 156 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2023 | 1928 | 0.050 |
Why?
| | Perception | 1 | 2023 | 340 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 336 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 487 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1876 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2023 | 601 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 174 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 503 | 0.040 |
Why?
| | Aged | 1 | 2016 | 22103 | 0.030 |
Why?
| | Rickets | 1 | 2017 | 9 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 966 | 0.030 |
Why?
| | Phosphorus | 1 | 2017 | 93 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 146 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1309 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 751 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1952 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2717 | 0.020 |
Why?
| | Calcium | 1 | 2017 | 1213 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1266 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7133 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5406 | 0.020 |
Why?
| | Animals | 1 | 2015 | 35361 | 0.010 |
Why?
|
|
Simmons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|